The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial.
Data(s) |
01/01/2014
|
---|---|
Resumo |
The aim of the Youth Depression Alleviation-Combined Treatment (YoDA-C) study is to determine whether antidepressant medication should be started as a first-line treatment for youth depression delivered concurrently with psychotherapy. Doubts about the use of medication have been raised by meta-analyses in which the efficacy and safety of antidepressants in young people have been questioned, and subsequent treatment guidelines for youth depression have provided only qualified support. |
Identificador | |
Idioma(s) |
eng |
Publicador |
BioMed Central |
Relação |
http://dro.deakin.edu.au/eserv/DU:30069436/berk-additionoffluoxetine-2014.pdf http://www.dx.doi.org/10.1186/1745-6215-15-425 http://www.ncbi.nlm.nih.gov/pubmed/25370185 |
Direitos |
2014, BioMed Central |
Palavras-Chave | #Adolescence #Antidepressants #Cognitive behavioural therapy #Depression #Fluoxetine #Selective serotonin reuptake inhibitors #Youth #Science & Technology #Life Sciences & Biomedicine #Medicine, Research & Experimental #Research & Experimental Medicine #PLACEBO-CONTROLLED TRIAL #MAJOR DEPRESSION #DOUBLE-BLIND #ANTIDEPRESSANT TREATMENT #COMMUNITY SAMPLE #SELF-REPORT #ADOLESCENTS #DISORDER #CHILDREN #METAANALYSIS |
Tipo |
Journal Article |